开放吻合器行业研究报告（附行业政策、产业链全景分析、竞争格局及发展趋势预测）

Core Insights - The open stapler market in China is experiencing a declining trend, with a market size of 15.3 billion yuan in 2020 due to the pandemic, and projected to decrease to 14.1 billion yuan by 2024, reflecting a year-on-year decline of 2.1% [4][7][13]. Market Overview - Open staplers are primarily used in traditional open surgeries, replacing manual suturing with mechanical devices for tissue cutting and anastomosis [4][6]. - The market size for open staplers increased from 2017 to 2019 but faced a downturn starting in 2020, with a recovery in 2021 followed by a projected decline from 2022 to 2024 [7][13]. - The decline is attributed to advancements in surgical techniques, with minimally invasive procedures becoming the mainstream, leading to the rapid adoption of laparoscopic staplers [4][7]. Industry Dynamics - The open stapler industry consists of upstream material suppliers, midstream manufacturers, and downstream healthcare institutions, which are the primary consumers [6][10]. - The number of healthcare institutions in China is on the rise, expected to reach 1,093,600 by 2024, indicating a growing demand for medical devices, including open staplers [6][7]. Competitive Landscape - Despite the shrinking market, the competitive ecosystem remains stable, with foreign giants like Johnson & Johnson and Medtronic dominating the high-end market due to their technological advantages and brand reputation [7][8]. - Domestic companies are leveraging local production to control costs and meet the procurement needs of hospitals, while also focusing on R&D to enhance product performance [7][8]. Future Trends - Future technological advancements in open staplers will focus on enhancing safety, efficiency, and precision, with the integration of sensors and microprocessors for intelligent control of stapling force and cutting speed [8][9]. - Open staplers will concentrate on specific application scenarios to strengthen their competitive edge against laparoscopic alternatives [8].